1 research outputs found

    Vx3-Functionalized Alumina Nanoparticles Assisted Enrichment of Ubiquitinated Proteins from Cancer Cells for Enhanced Cancer Immunotherapy

    No full text
    A simple and effective strategy was developed to enrich ubiquitinated proteins (UPs) from cancer cell lysate using the α-Al<sub>2</sub>O<sub>3</sub> nanoparticles covalently linked with ubiquitin binding protein (Vx3) (denoted as α-Al<sub>2</sub>O<sub>3</sub>–Vx3) via a chemical linker. The functionalized α-Al<sub>2</sub>O<sub>3</sub>–Vx3 showed long-term stability and high efficiency for the enrichment of UPs from cancer cell lysates. Flow cytometry analysis results indicated dendritic cells (DCs) could more effectively phagocytize the covalently linked α-Al<sub>2</sub>O<sub>3</sub>–Vx3-UPs than the physical mixture of α-Al<sub>2</sub>O<sub>3</sub> and Vx3-UPs (α-Al<sub>2</sub>O<sub>3</sub>/Vx3-UPs). Laser confocal microscopy images revealed that α-Al<sub>2</sub>O<sub>3</sub>–Vx3-UPs localized within the autophagosome of DCs, which then cross-presented α-Al<sub>2</sub>O<sub>3</sub>–Vx3-UPs to CD8<sup>+</sup> T cells in an autophagosome-related cross-presentation pathway. Furthermore, α-Al<sub>2</sub>O<sub>3</sub>–Vx3-UPs enhanced more potent antitumor immune response and antitumor efficacy than α-Al<sub>2</sub>O<sub>3</sub>/cell lysate or α-Al<sub>2</sub>O<sub>3</sub>/Vx3-UPs. This work highlights the potential of using the Vx3 covalently linked α-Al<sub>2</sub>O<sub>3</sub> as a simple and effective platform to enrich UPs from cancer cells for the development of highly efficient therapeutic cancer vaccines
    corecore